Eledon Pharma Stock (NASDAQ: ELDN) stock price, news, charts, stock research, profile.
Open | $2.63 |
Close | $2.64 |
Volume / Avg. | 109.79K / 210.77K |
Day Range | 2.45 - 2.65 |
52 Wk Range | 1.07 - 3.35 |
Market Cap | $96.65M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 0.16% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Eledon Pharma (NASDAQ:ELDN) through any online brokerage.
Other companies in Eledon Pharma’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO), FibroGen (NASDAQ:FGEN) and Armata Pharmaceuticals (AMEX:ARMP).
There is no analysis for Eledon Pharma.
Eledon Pharma has a consensus price target of $15.25.
The stock price for Eledon Pharma (NASDAQ: ELDN) is $2.51 last updated June 28, 2024 at 5:10 PM EDT.
There are no upcoming dividends for Eledon Pharma.
Eledon Pharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Eledon Pharma.
Eledon Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.